Clinical Trial Update: Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying micronized and ultramicronized palmitoylethanolamide in fibromyalgia patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: Epitech Group SpA | Conditions: Fibromyalgia | Phase 4 | Status: COMPLETED